These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

887 related items for PubMed ID: 29674323

  • 1. Hemoglobin A1c Accurately Predicts Continuous Glucose Monitoring-Derived Average Glucose in Youth and Young Adults With Cystic Fibrosis.
    Chan CL, Hope E, Thurston J, Vigers T, Pyle L, Zeitler PS, Nadeau KJ.
    Diabetes Care; 2018 Jul; 41(7):1406-1413. PubMed ID: 29674323
    [Abstract] [Full Text] [Related]

  • 2. Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes.
    Chan CL, Pyle L, Kelsey MM, Newnes L, Baumgartner A, Zeitler PS, Nadeau KJ.
    Pediatr Diabetes; 2017 Nov; 18(7):629-636. PubMed ID: 27873436
    [Abstract] [Full Text] [Related]

  • 3. Continuous glucose monitoring and advanced glycation endproducts for prediction of clinical outcomes and development of cystic fibrosis-related diabetes in adults with CF.
    Scully KJ, Brenner L, Martin K, Ruazol M, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Putman MS.
    Front Endocrinol (Lausanne); 2024 Nov; 15():1293709. PubMed ID: 38379863
    [Abstract] [Full Text] [Related]

  • 4. Screening for cystic fibrosis-related diabetes and prediabetes: Evaluating 1,5-anhydroglucitol, fructosamine, glycated albumin, and hemoglobin A1c.
    Tommerdahl KL, Brinton JT, Vigers T, Nadeau KJ, Zeitler PS, Chan CL.
    Pediatr Diabetes; 2019 Dec; 20(8):1080-1086. PubMed ID: 31469470
    [Abstract] [Full Text] [Related]

  • 5. Screening for type 2 diabetes and prediabetes in obese youth: evaluating alternate markers of glycemia - 1,5-anhydroglucitol, fructosamine, and glycated albumin.
    Chan CL, Pyle L, Kelsey M, Newnes L, Zeitler PS, Nadeau KJ.
    Pediatr Diabetes; 2016 May; 17(3):206-11. PubMed ID: 25652226
    [Abstract] [Full Text] [Related]

  • 6. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease.
    Zelnick LR, Batacchi ZO, Ahmad I, Dighe A, Little RR, Trence DL, Hirsch IB, de Boer IH.
    Diabetes Care; 2020 Oct; 43(10):2379-2387. PubMed ID: 32788282
    [Abstract] [Full Text] [Related]

  • 7. Improved Detection of Abnormal Glucose Tolerance in Africans: The Value of Combining Hemoglobin A1c With Glycated Albumin.
    Hobabagabo AF, Osei-Tutu NH, Hormenu T, Shoup EM, DuBose CW, Mabundo LS, Ha J, Sherman A, Chung ST, Sacks DB, Sumner AE.
    Diabetes Care; 2020 Oct; 43(10):2607-2613. PubMed ID: 32801129
    [Abstract] [Full Text] [Related]

  • 8. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring.
    Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C, Diabetes Research in Children Network (DirecNet) Study Group.
    Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193
    [Abstract] [Full Text] [Related]

  • 9. [Indicators of glycemic control --hemoglobin A1c (HbA1c), glycated albumin (GA), and 1,5-anhydroglucitol (1,5-AG)].
    Sato A.
    Rinsho Byori; 2014 Jan; 62(1):45-52. PubMed ID: 24724426
    [Abstract] [Full Text] [Related]

  • 10. Glycated Albumin Correlates With Time-in-Range Better Than HbA1c or Fructosamine.
    Desouza CV, Rosenstock J, Kohzuma T, Fonseca VA.
    J Clin Endocrinol Metab; 2023 Oct 18; 108(11):e1193-e1198. PubMed ID: 37259605
    [Abstract] [Full Text] [Related]

  • 11. Continuous Glucose Monitoring and HbA1c in Cystic Fibrosis: Clinical Correlations and Implications for CFRD Diagnosis.
    Scully KJ, Sherwood JS, Martin K, Ruazol M, Marchetti P, Larkin M, Zheng H, Sawicki GS, Uluer A, Neuringer I, Yonker LM, Sicilian L, Wexler DJ, Putman MS.
    J Clin Endocrinol Metab; 2022 Mar 24; 107(4):e1444-e1454. PubMed ID: 34850006
    [Abstract] [Full Text] [Related]

  • 12. Traditional and nontraditional glycemic markers and risk of peripheral artery disease: The Atherosclerosis Risk in Communities (ARIC) study.
    Ding N, Kwak L, Ballew SH, Jaar B, Hoogeveen RC, Ballantyne CM, Sharrett AR, Folsom AR, Heiss G, Salameh M, Coresh J, Hirsch AT, Selvin E, Matsushita K.
    Atherosclerosis; 2018 Jul 24; 274():86-93. PubMed ID: 29753232
    [Abstract] [Full Text] [Related]

  • 13. Assessment of Glycemic Control by Continuous Glucose Monitoring, Hemoglobin A1c, Fructosamine, and Glycated Albumin in Patients With End-Stage Kidney Disease and Burnt-Out Diabetes.
    Kaminski CY, Galindo RJ, Navarrete JE, Zabala Z, Moazzami B, Gerges A, McCoy RG, Fayfman M, Vellanki P, Idrees T, Peng L, Umpierrez GE.
    Diabetes Care; 2024 Feb 01; 47(2):267-271. PubMed ID: 38085705
    [Abstract] [Full Text] [Related]

  • 14. The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus.
    Shima K, Abe F, Chikakiyo H, Ito N.
    Diabetes Res Clin Pract; 1989 Nov 06; 7(4):243-50. PubMed ID: 2612342
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Glycemic Markers in Chronic Hemodialysis Using Continuous Glucose Monitoring.
    Divani M, Georgianos PI, Didangelos T, Iliadis F, Makedou A, Hatzitolios A, Liakopoulos V, Grekas DM.
    Am J Nephrol; 2018 Nov 06; 47(1):21-29. PubMed ID: 29275415
    [Abstract] [Full Text] [Related]

  • 16. GLYCATED ALBUMIN AT 4 WEEKS CORRELATES WITH A1C LEVELS AT 12 WEEKS AND REFLECTS SHORT-TERM GLUCOSE FLUCTUATIONS.
    Desouza CV, Rosenstock J, Zhou R, Holcomb RG, Fonseca VA.
    Endocr Pract; 2015 Nov 06; 21(11):1195-203. PubMed ID: 26214108
    [Abstract] [Full Text] [Related]

  • 17. A1C Combined With Glycated Albumin Improves Detection of Prediabetes in Africans: The Africans in America Study.
    Sumner AE, Duong MT, Aldana PC, Ricks M, Tulloch-Reid MK, Lozier JN, Chung ST, Sacks DB.
    Diabetes Care; 2016 Feb 06; 39(2):271-7. PubMed ID: 26681716
    [Abstract] [Full Text] [Related]

  • 18. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study.
    Jung M, Warren B, Grams M, Kwong YD, Shafi T, Coresh J, Rebholz CM, Selvin E.
    J Diabetes; 2018 Apr 06; 10(4):276-285. PubMed ID: 29055090
    [Abstract] [Full Text] [Related]

  • 19. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring.
    Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ.
    Nephrology (Carlton); 2012 Feb 06; 17(2):182-8. PubMed ID: 21883672
    [Abstract] [Full Text] [Related]

  • 20. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices.
    Desouza CV, Holcomb RG, Rosenstock J, Frias JP, Hsia SH, Klein EJ, Zhou R, Kohzuma T, Fonseca VA.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):677-87. PubMed ID: 31650161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 45.